AI Resilience Report forOrthopedic Surgeons, Except Pediatric

Right now, AI in orthopedic surgery is almost entirely about augmentation — helping surgeons do their job better — rather than replacing them. The actual operating (drilling, cutting, implanting) is still done by humans, often with robotic arms that respond to the surgeon's hands. A 2026 review explains that artificial intelligence improves early detection of musculoskeletal conditions, supports risk prediction, and enables patient-specific treatment planning through advanced data analysis and image interpretation, while robotic systems enhance surgical consistency and safety by providing real-time guidance, mechanical precision, and controlled execution of complex procedures.

In knee replacements specifically, robot-assisted procedures have been reported to demonstrate improved implant alignment and bone resection accuracy when compared to conventional approaches, and AI-assisted preoperative planning can reduce the need for intraoperative modifications by 39.7% in selected cohorts. The most recent JBJS specialty update highlights AI as a "triage" helper — for example, a convolutional neural network that predicts operative vs. nonoperative treatment of distal radial fractures with 88% accuracy, which the authors describe as a tool to augment existing care pathways. Surgeons themselves describe the change as practical, not science-fiction: at HSS in New York, Dr. Jonathan Vigdorchik told Becker's ^[1] that surgical case planning that "used to spend 30 minutes to an hour" can now be done reliably in seconds, and ambient AI listening generates office notes without the surgeon turning away from the patient.

Adoption is happening, but unevenly. On the upside, big device makers have made AI core to their products: a recap of the AAOS 2026 Annual Meeting ^[2] notes that AI is being embedded into the architecture of major products like Zimmer Biomet's ROSA ecosystem, Smith+Nephew's CORIOGRAPH planning service, and Stryker's Blueprint software, reflecting a pivot where the data-enabled surgical workflow is the product and the implant is the revenue-generating component within it. A 2026 Springer Nature review of robotic TKA adoption ^[3] finds that robotic-assisted TKA has evolved from a niche innovation to a mainstream surgical approach, with North America leading utilization and adoption poised to become the dominant technique in many markets by the end of the decade.

The slowdowns are real, though: high initial procurement costs, together with ongoing expenses for system maintenance, technical support, and consumables, remain among the most significant barriers to widespread adoption, and rural or smaller hospitals struggle to justify the investment. Regulators add caution — AI-driven surgical systems face lengthy and stringent approval processes, which can delay product deployment and scalability. And the JBJS Specialty Update ^[4] warns that if noisy or biased data are used to train an algorithm, the predictions will likewise be unreliable or biased.

The bottom line for students: orthopedic surgery requires hand skills, real-time judgment, and patient trust that AI can't replicate — so this career looks like one where AI becomes a powerful teammate, not a replacement.